Sterility assay, line item 119 units: each catalog#: 510120GMP.BSV
Ended Awarded Last action
- Contract number
- HHSN26100033
- Awardee
-
Bioreliance Corporation UEI H3KAG9A26K77 Part of Sigma-Aldrich Corporation
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $36,008
Award facts
- Contract value 100% obligated
- $36,008.23 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541380 Testing Laboratories and Services
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $36,008 |
About this award
This federal contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Bioreliance Corporation, a foreign-owned for-profit organization, to provide sterility assay testing services. The contract, valued at $36,008.23, is a firm fixed-price delivery order with a completion date of June 30, 2013. Bioreliance Corporation, through its Life Sciences Services division, has extensively supported HHS and NIH agencies like the National Institute of Allergy and Infectious Diseases (NIAID) in the past by providing various types of testing services for investigational new drug applications, including isolator sterility testing, endotoxin testing, general safety testing, and microbiological examination. The parent company of Bioreliance Corporation is Sigma-Aldrich Corporation, a leading supplier of laboratory chemicals and related materials, which has served as a subcontractor for federal contracts in the life sciences industry. No set-aside designation is specified for this contract.
Quick answers
Who was awarded contract HHSN26100033?
HHSN26100033 was awarded to Bioreliance Corporation by National Cancer Institute (National Institutes of Health) on February 1, 2013.
How much is contract HHSN26100033 worth?
The government has obligated $36,008 on HHSN26100033.
Is contract HHSN26100033 an order under another contract?
Yes. HHSN26100033 is a delivery order under HHSN261200900022I, an indefinite delivery contract.
Was contract HHSN26100033 competed?
The extent of competition for HHSN26100033 was competed under sap. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award